halothane has been researched along with ritanserin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azerad, J; Desmonts, JM; Limoge, A; Mantz, J | 1 |
Gerdes, C; Löscher, W; Richter, A | 1 |
Löscher, W; Richter, A; Scholz, J; Tonner, PH; Wappler, F | 1 |
Fiege, M; Richter, A; Scholz, J; Schulte am Esch, J; Steinfath, M; Wappler, F; Weisshorn, R | 1 |
4 other study(ies) available for halothane and ritanserin
Article | Year |
---|---|
Transcranial electrical stimulation with Limoge's currents decreases halothane requirements in rats. Evidence for the involvement of endogenous opioids.
Topics: Anesthesia, Inhalation; Animals; Electric Stimulation; Enkephalins; Halothane; Male; Methysergide; Naloxone; Neprilysin; Rats; Rats, Inbred Strains; Ritanserin; Thiorphan; Yohimbine | 1992 |
Lack of prophylactic or therapeutic efficacy of 5-HT2A receptor antagonists in halothane-induced porcine malignant hyperthermia.
Topics: Animals; Blood Pressure; Body Temperature; Dantrolene; Female; Halothane; Heart Rate; Ketanserin; Male; Malignant Hyperthermia; Premedication; Ritanserin; Species Specificity; Swine | 1994 |
Effects of the 5-HT2 receptor antagonist ritanserin on halothane-induced increase of inositol phosphates in porcine malignant hyperthermia.
Topics: Anesthetics, Inhalation; Animals; Halothane; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Malignant Hyperthermia; Muscle, Skeletal; Ritanserin; Serotonin Antagonists; Swine | 1996 |
5-HT2 receptor antagonist-mediated inhibition of halothane-induced contractures in skeletal muscle specimens from malignant hyperthermia susceptible patients.
Topics: Adolescent; Adult; Anesthetics, Inhalation; Caffeine; Child; Dose-Response Relationship, Drug; Drug Interactions; Halothane; Humans; Malignant Hyperthermia; Middle Aged; Muscle Contraction; Muscle, Skeletal; Ritanserin; Serotonin Antagonists; Time Factors | 1999 |